219 related articles for article (PubMed ID: 29682897)
1. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
[TBL] [Abstract][Full Text] [Related]
4. Human Reticular Acellular Dermal Matrix in the Healing of Chronic Diabetic Foot Ulcerations that Failed Standard Conservative Treatment: A Retrospective Crossover Study.
Zelen CM; Orgill DP; Serena TE; Galiano RD; Carter MJ; DiDomenico LA; Kaufman JP; Keller J; Young NJ; Li WW
Wounds; 2017 Feb; 29(2):39-45. PubMed ID: 28272011
[TBL] [Abstract][Full Text] [Related]
5. Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.
Lantis JC; Snyder R; Reyzelman AM; Van Gils CC; Sigal F; Vayser D; Caporusso JM; Cazzell S; Lavery LA;
J Wound Care; 2021 Jul; 30(Sup7):S18-S27. PubMed ID: 34256588
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers.
Cazzell S
Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443
[TBL] [Abstract][Full Text] [Related]
7. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
[TBL] [Abstract][Full Text] [Related]
8. [Meta-analysis on the clinical effects of allogenic acellular dermal matrix treatment for diabetic foot ulcer].
Xue CL; Hu ZC; Yang ZX; Li XJ
Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):725-729. PubMed ID: 28043296
[No Abstract] [Full Text] [Related]
9. Human-derived Acellular Dermal Matrix Grafts for Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-analysis.
Luthringer M; Mukherjee T; Arguello-Angarita M; Granick MS; Alvarez OM
Wounds; 2020 Feb; 32(2):57-65. PubMed ID: 32155123
[TBL] [Abstract][Full Text] [Related]
10. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis.
Reyzelman AM; Bazarov I
J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis.
Guo X; Mu D; Gao F
Int J Surg; 2017 Apr; 40():1-7. PubMed ID: 28232031
[TBL] [Abstract][Full Text] [Related]
12. A Prospective, Multicenter, Single-Arm Clinical Trial for Treatment of Complex Diabetic Foot Ulcers with Deep Exposure Using Acellular Dermal Matrix.
Cazzell S; Moyer PM; Samsell B; Dorsch K; McLean J; Moore MA
Adv Skin Wound Care; 2019 Sep; 32(9):409-415. PubMed ID: 31361269
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
Zelen CM; Serena TE; Gould L; Le L; Carter MJ; Keller J; Li WW
Int Wound J; 2016 Apr; 13(2):272-82. PubMed ID: 26695998
[TBL] [Abstract][Full Text] [Related]
14. Use of a human acellular dermal wound matrix in patients with complex wounds and comorbidities.
Williams ML; Holewinski JE
J Wound Care; 2015 Jun; 24(6):261-2, 264-7. PubMed ID: 26075374
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Hard-to-heal Diabetic Foot Ulcers With a Hepatic-derived Wound Matrix.
Fridman R; Rafat P; Van Gils CC; Horn D; Vayser D; Lambert JC
Wounds; 2020 Sep; 32(9):244-252. PubMed ID: 32813669
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
[TBL] [Abstract][Full Text] [Related]
17. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
Serena TE; Bullock NM; Cole W; Lantis J; Li L; Moore S; Patel K; Sabo M; Wahab N; Price P
J Wound Care; 2021 May; 30(Sup5):S7-S14. PubMed ID: 33979229
[TBL] [Abstract][Full Text] [Related]
18. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
[TBL] [Abstract][Full Text] [Related]
19. Composite Skin Grafting with Human Acellular Dermal Matrix Scaffold for Treatment of Diabetic Foot Ulcers: A Randomized Controlled Trial.
Hu Z; Zhu J; Cao X; Chen C; Li S; Guo D; Zhang J; Liu P; Shi F; Tang B
J Am Coll Surg; 2016 Jun; 222(6):1171-9. PubMed ID: 27068845
[TBL] [Abstract][Full Text] [Related]
20. Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: Interim results of a comparative efficacy randomized controlled trial.
Tchanque-Fossuo CN; Dahle SE; Lev-Tov H; West KIM; Li CS; Rocke DM; Isseroff RR
J Tissue Eng Regen Med; 2019 Aug; 13(8):1430-1437. PubMed ID: 31070860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
